UK health regulator has made eight observations at Alkem Laboratories’ manufacturing plant at Taloja, Maharashtra. The Medicines and Healthcare Products Regulator Agency (UKMHRA) had conducted an inspection at the company's facility at Taloja earlier this month with respect to marketing authorisation applications made by the company to the EU countries. The company has received inspection report from the UKMHRA on March 30 where 8 observations have been made by the regulator.
Alkem Laboratories is engaged in manufacturing and distributing pharmaceuticals products. It offers active pharmaceutical ingredient (API), generic, branded and nutraceuticals products under the brand name Clavm, Pan20, Pan40, Sumo. The firm also provides formulations for acute and chronic therapeutic focusing on anti-infective, gastrointestinal, cardiovascular, anti-diabetic, and pain management segments.
